Skip to main content
. 2024 Nov 29;52(11):03000605241300067. doi: 10.1177/03000605241300067

Figure 2.

Figure 2.

High biglycan (BGN) protein levels indicate a poor prognosis for colon cancer patients. (a) Representative images of BGN immunostaining in tissue microarrays from 93 colon cancer patients. (b & c) Kaplan–Meier analyses of overall survival and disease-free survival based on low and high BGN protein levels in these 93 colon cancer patients. The colour version of this figure is available at: http://imr.sagepub.com.